reSee.it Video Transcript AI Summary
A meeting occurred in June involving biopharma, the military, DARPA, and ASPR, focusing on medical countermeasures. The DOD is planning for a future event, allowing biopharma companies to manufacture countermeasures before FDA approval, similar to how COVID shots were stockpiled.
The meeting, titled "Partnering with US government to achieve our national security mission," indicates a planned public health threat that will impact national security. The aim is to advance defense readiness through DOD partnerships for rapid development and deployment of medical countermeasures. AI will be used without safety or efficacy testing, creating dual-use products that could be weaponized. Laws have been rewritten, making the PREP Act seem minor in comparison, potentially deputizing police or doctors as DOD employees.
Deployment methods may include spraying schools, cruise ships, or communities, or using transdermal patches, not just injections. DARPA has been funding dual-use products, turning military bioweapons into an industry.